Trials / Recruiting
RecruitingNCT07349498
Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation
Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation (CORE-HCT): A Prospective Multicenter Observational Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 10,000 (estimated)
- Sponsor
- Peking University People's Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is a prospective, multicenter observational study for recipients of hematopoietic stem cell transplantation. Patients who underwent hematopoietic stem cell transplantation at the participating centers will be entrolled in the study. The clinical characteristics, laboratory profiles, management measures, and clinical outcomes such as post-transplant cardiovascular events will be prospectively collected.
Conditions
Timeline
- Start date
- 2026-01-01
- Primary completion
- 2036-06-30
- Completion
- 2036-12-31
- First posted
- 2026-01-16
- Last updated
- 2026-01-16
Locations
16 sites across 1 country: China
Source: ClinicalTrials.gov record NCT07349498. Inclusion in this directory is not an endorsement.